However, CD133 is not the only marker useful for prospective identification of glioma stem cells, not all CD133+ cells are GSCs, and CD133 cannot exclusively segregate for tumorigenic potential and self-renewal in all glioma patient samples and cell lines studied [27]–[33]. Here, PROM1 is linked to central nervous system cancer.